Viba Therapeutics Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Viba Therapeutics General Information


Developer of humanized monoclonal antibody therapeutics designed to treat of solid tumors. The company's therapeutics initiate and drive the progression and metastasis of numerous malignancies, including breast, pancreatic, ovarian, prostate and colorectal cancer, enabling healthcare providers to treat their patients and improve their lives.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • 1700 Owens Street
  • Suite 515
  • San Francisco, CA 94158
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Viba Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Sep-2018 00.000 Completed Out of Business
1. Early Stage VC 26-Apr-2016 00.000 00.000 Completed Startup
To view Viba Therapeutics’s complete valuation and funding history, request access »